We and others have previously reported that IFNγ levels are elevated in individuals with obesity and obese animals, and reduced IFNγ levels are associated with improved insulin action and glucose metabolism14,16–18. The gene discussed is IFNG; the disease is obesity due to melanocortin 4 receptor deficiency.